){kind=logo}
)
De Martin Alexander Gershon, MD, JD, MPH
Managing Partner and Chief Strategy Officer,
Endeavor
Dr. Martin Alexander Gershon, MD, JD, MPH is the Managing Partner and Chief Strategy Officer of the Endeavor Group, which includes its three subsidiaries: Endeavor Venture Capital, Endeavor Communications and Media, and Endeavor Strategic Growth Advisors. In addition he serves as the Senior Executive Investor-in-Residence and Lead Mentor-in-Residence at Techstars, Advisor to the White House Moonshot CancerX Accelerator, and Senior Advisor to well known Fortune 500 Companies in Healthcare, Big Tech and Financial Services.
Dr. Gershon is recognized as one of the leading healthcare investors, growth strategists, and futurists. He is a Linkedin “Top Voice” in Venture Capital and Entrepreneurship, honored by Standard and Poor’s as a designated Top 100 Healthcare Industry Leader, and featured on CNBC and in numerous conferences and publications as a change-maker who has built a reputation on his prescient, future facing investment decisions, often coining the philosophy of “skating to where the puck is going, not where it is.”
Since 1999 Dr. Gershon has led Endeavor Venture Funds I, II, and III to over 100 investments and 24 exits, founded 6 startups, and built a thriving ecosystem of partnerships and collaborations. This deep network includes C-Suite thought leaders from Biopharma, Biotech, Healthtech, Big Tech, Investment Banking and Venture Capital, and renowned Ivy League Academic Medical Centers and Business Schools. Some of our strongest partners include Microsoft, Google, Nvidia, Merck, Sanofi, Novartis, Roche, Bayer, HSBC, JPMorgan, Mount Sinai, Mass General Brigham, Memorial Sloan-Kettering Cancer Center, the National Institutes of Health, Johns Hopkins Advanced Biotechnology, Columbia-Presbyterian Medical Center, McGill Medical Center, and Harvard, NYU, and Columbia Business Schools.
Endeavor has created an ecosystem that creates resilient CEO/Entrepreneurs and sustainable funding for development, growth, commercialization and scalability from Seed Stage to Series B. We believe this Future Proofs our portfolio companies, building great leaders, strong teams, and companies that can withstand any crisis.
Over the past 25 years Endeavor Strategic Growth Advisory and Dr. Gershon has served as a Senior Strategic Advisor dedicated to developing growth strategies and commercializing innovative technologies for prominent Fortune 500 Companies, and global leaders including Microsoft, McKinsey, Goldman Sachs, Bain Capital, BlackRock, American Express, Tiger Global, Caxton, AIG, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Fidelity Investments, Pictet Asset Management, Senator Hillary Rodham Clinton, Senator John Kerry, Ambassador Richard Holbrooke, the Federal Reserve Board of Governors, the Bill and Melinda Gates Foundation, NY Economic Development Corporation, and the Rockefeller Foundation.
Dr. Gershon also has an esteemed academic, teaching and mentoring career. He is a Harvard, McGill and Columbia trained neuroscientist, oncologist and immunologist, former FDA attorney, an award winning Google Scholar in Entrepreneurship, and Juilliard trained musician. He has served as the Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Executive-in-Residence Matter Health, and has been a Senior Lecturer of Healthcare Economics and Entrepreneurship at Johns Hopkins in the Advanced Biotechnology Program, Guest Lecturer of Healthcare AI and Venture Investing at the Johns Hopkins School of Business, Professor of Healthcare Policy and Finance at Columbia School of Public Health, Professor of Healthcare Innovation and Entrepreneurship and Chief Innovation and Investment Officer at McGill, Guest Lecturer of Drug Development and Drug Discovery at Harvard and MIT in the Health, Science and Technology Program, and Guest Lecturer of Healthcare AI and Digital Innovation at the NYU Entrepreneurial Institute and the School for Professional Studies.
Dr. Gershon is recognized as one of the leading healthcare investors, growth strategists, and futurists. He is a Linkedin “Top Voice” in Venture Capital and Entrepreneurship, honored by Standard and Poor’s as a designated Top 100 Healthcare Industry Leader, and featured on CNBC and in numerous conferences and publications as a change-maker who has built a reputation on his prescient, future facing investment decisions, often coining the philosophy of “skating to where the puck is going, not where it is.”
Since 1999 Dr. Gershon has led Endeavor Venture Funds I, II, and III to over 100 investments and 24 exits, founded 6 startups, and built a thriving ecosystem of partnerships and collaborations. This deep network includes C-Suite thought leaders from Biopharma, Biotech, Healthtech, Big Tech, Investment Banking and Venture Capital, and renowned Ivy League Academic Medical Centers and Business Schools. Some of our strongest partners include Microsoft, Google, Nvidia, Merck, Sanofi, Novartis, Roche, Bayer, HSBC, JPMorgan, Mount Sinai, Mass General Brigham, Memorial Sloan-Kettering Cancer Center, the National Institutes of Health, Johns Hopkins Advanced Biotechnology, Columbia-Presbyterian Medical Center, McGill Medical Center, and Harvard, NYU, and Columbia Business Schools.
Endeavor has created an ecosystem that creates resilient CEO/Entrepreneurs and sustainable funding for development, growth, commercialization and scalability from Seed Stage to Series B. We believe this Future Proofs our portfolio companies, building great leaders, strong teams, and companies that can withstand any crisis.
Over the past 25 years Endeavor Strategic Growth Advisory and Dr. Gershon has served as a Senior Strategic Advisor dedicated to developing growth strategies and commercializing innovative technologies for prominent Fortune 500 Companies, and global leaders including Microsoft, McKinsey, Goldman Sachs, Bain Capital, BlackRock, American Express, Tiger Global, Caxton, AIG, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Fidelity Investments, Pictet Asset Management, Senator Hillary Rodham Clinton, Senator John Kerry, Ambassador Richard Holbrooke, the Federal Reserve Board of Governors, the Bill and Melinda Gates Foundation, NY Economic Development Corporation, and the Rockefeller Foundation.
Dr. Gershon also has an esteemed academic, teaching and mentoring career. He is a Harvard, McGill and Columbia trained neuroscientist, oncologist and immunologist, former FDA attorney, an award winning Google Scholar in Entrepreneurship, and Juilliard trained musician. He has served as the Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Executive-in-Residence Matter Health, and has been a Senior Lecturer of Healthcare Economics and Entrepreneurship at Johns Hopkins in the Advanced Biotechnology Program, Guest Lecturer of Healthcare AI and Venture Investing at the Johns Hopkins School of Business, Professor of Healthcare Policy and Finance at Columbia School of Public Health, Professor of Healthcare Innovation and Entrepreneurship and Chief Innovation and Investment Officer at McGill, Guest Lecturer of Drug Development and Drug Discovery at Harvard and MIT in the Health, Science and Technology Program, and Guest Lecturer of Healthcare AI and Digital Innovation at the NYU Entrepreneurial Institute and the School for Professional Studies.
Sessions
-
10-Dec-2025Start-up & Investor VillagePitch & Partner: VC-Startup Exchange
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
.svg){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.jpg/fit-in/500x500/filters:no_upscale()){kind=logo}
)
)
){kind=logo}
)
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)